Analytical Data
-
Gene name
KLF2
- Application
-
Alternative Names
KLF2;LKLF;Krueppel-like factor 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y5W3
-
Expression Region
1-355aa
-
AA Sequence
MALSEPILPS FSTFASPCRE RGLQERWPRA EPESGGTDDD LNSVLDFILS MGLDGLGAEA APEPPPPPPP PAFYYPEPGA PPPYSAPAGG LVSELLRPEL DAPLGPALHG RFLLAPPGRL VKAEPPEADG GGGYGCAPGL TRGPRGLKRE GAPGPAASCM RGPGGRPPPP PDTPPLSPDG PARLPAPGPR ASFPPPFGGP GFGAPGPGLH YAPPAPPAFG LFDDAAAAAA ALGLAPPAAR GLLTPPASPL ELLEAKPKRG RRSWPRKRTA THTCSYAGCG KTYTKSSHLK AHLRTHTGEK PYHCNWDGCG WKFARSDELT RHYRKHTGHR PFQCHLCDRA FSRSDHLALH MKRHM
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KLF2, or Krüppel-like factor 2, is a key transcription factor that plays a critical role in various biological processes, including vascular biology, inflammation, and immune response regulation. It is widely recognized for its protective effects in endothelial cells and its involvement in maintaining vascular homeostasis. Research has shown that KLF2 is essential for modulating the expression of genes related to cell adhesion, migration, and survival, making it a significant player in cardiovascular health. The recombinant protein of KLF2 has garnered interest due to its potential therapeutic applications, particularly in regenerative medicine and tissue engineering. By studying KLF2 recombinant proteins, researchers aim to understand its mechanism of action more thoroughly, explore its role in therapeutic angiogenesis, and evaluate its implications in diseases such as atherosclerosis and diabetes. Additionally, generating KLF2 as a recombinant protein allows scientists to investigate its interactions with other proteins and cellular pathways, paving the way for novel interventions targeting cardiovascular and inflammatory diseases. This growing body of research holds promise not only for elucidating KLF2's biological functions but also for developing innovative strategies to harness its potential in clinical settings.











